GILZ formulations for wound healing
US11524091B2 · kind B2 · utility
0Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2019 |
| Grant date | Dec 13, 2022 |
| Priority date | — |
| Expiry date | Aug 15, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/252
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Glucocorticoid-induced leucine zipper protein (GILZ) peptide compositions and their methods of use in wound healing are disclosed herein. An exemplary GILZ peptide composition includes a GILZ fusion protein. The GILZ peptide compositions can be administered topically to wounds, for example in the form of a cream, ointment, or lotion. The GILZ peptide compositions can be used to treat acute wounds, induce wound healing in chronic wounds, and reduce scar formation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.